120 related articles for article (PubMed ID: 12480180)
1. Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations.
Itokawa M; Lin Z; Uhl GR
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):71-80. PubMed ID: 12480180
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression.
Lin Z; Itokawa M; Uhl GR
FASEB J; 2000 Apr; 14(5):715-28. PubMed ID: 10744628
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
Lin Z; Wang W; Uhl GR
Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.
Lin Z; Wang W; Kopajtic T; Revay RS; Uhl GR
Mol Pharmacol; 1999 Aug; 56(2):434-47. PubMed ID: 10419565
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism.
Khoshbouei H; Wang H; Lechleiter JD; Javitch JA; Galli A
J Biol Chem; 2003 Apr; 278(14):12070-7. PubMed ID: 12556446
[TBL] [Abstract][Full Text] [Related]
6. An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.
Fraser R; Chen Y; Guptaroy B; Luderman KD; Stokes SL; Beg A; DeFelice LJ; Gnegy ME
Mol Pharmacol; 2014 Jul; 86(1):76-85. PubMed ID: 24753048
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
8. Induction by low Na+ or Cl- of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters.
Pifl C; Agneter E; Drobny H; Reither H; Singer EA
Br J Pharmacol; 1997 May; 121(2):205-12. PubMed ID: 9154329
[TBL] [Abstract][Full Text] [Related]
9. Proline mutations induce negative-dosage effects on uptake velocity of the dopamine transporter.
Lin Z; Uhl GR
J Neurochem; 2005 Jul; 94(1):276-87. PubMed ID: 15953370
[TBL] [Abstract][Full Text] [Related]
10. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions.
Itokawa M; Lin Z; Cai NS; Wu C; Kitayama S; Wang JB; Uhl GR
Mol Pharmacol; 2000 Jun; 57(6):1093-103. PubMed ID: 10825379
[TBL] [Abstract][Full Text] [Related]
12. Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport.
Syringas M; Janin F; Mezghanni S; Giros B; Costentin J; Bonnet JJ
Mol Pharmacol; 2000 Dec; 58(6):1404-11. PubMed ID: 11093780
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism.
Lin Z; Uhl GR
Mol Pharmacol; 2002 Apr; 61(4):885-91. PubMed ID: 11901228
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine.
Chen N; Justice JB
Brain Res Mol Brain Res; 2000 Feb; 75(2):208-15. PubMed ID: 10686341
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
[TBL] [Abstract][Full Text] [Related]
18. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter.
Li LB; Chen N; Ramamoorthy S; Chi L; Cui XN; Wang LC; Reith ME
J Biol Chem; 2004 May; 279(20):21012-20. PubMed ID: 15024013
[TBL] [Abstract][Full Text] [Related]
19. Dopamine neuronal transport kinetics and effects of amphetamine.
Jones SR; Joseph JD; Barak LS; Caron MG; Wightman RM
J Neurochem; 1999 Dec; 73(6):2406-14. PubMed ID: 10582600
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]